Table of Contents China Cancer Supportive Care Medicine Market Report 2012-2023 1 Cancer Supportive Care Medicine Overview 1.1 Product Overview and Scope of Cancer Supportive Care Medicine 1.2 Classification of Cancer Supportive Care Medicine by Product Category 1.2.1 China Cancer Supportive Care Medicine Sales (K Units) Comparison by Types (2012-2023) 1.2.2 China Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 1.2.3 Antiemetic Drugs 1.2.4 Erythropoietin-Stimulating Agents 1.2.5 Granulocyte-Stimulating Agents 1.2.6 Analgesics 1.2.7 Others 1.3 China Cancer Supportive Care Medicine Market by Application/End Users 1.3.1 China Cancer Supportive Care Medicine (K Units) and Market Share Comparison by Applications (2012-2023) 1.3.2 Chemotherapy-Induced Anemia 1.3.3 CINV 1.3.4 Bone Metastasis 1.3.5 Cancer Pain 1.3.6 Other 1.4 China Cancer Supportive Care Medicine Market by Region 1.4.1 China Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions (2012-2023) 1.4.2 South China Status and Prospect (2012-2023) 1.4.3 East China Status and Prospect (2012-2023) 1.4.4 Southwest China Status and Prospect (2012-2023) 1.4.5 Northeast China Status and Prospect (2012-2023) 1.4.6 North China Status and Prospect (2012-2023) 1.4.7 Central China Status and Prospect (2012-2023) 1.4.8 Northwest China Status and Prospect (2012-2023) 1.5 China Sales and Revenue ofSales and Revenue of Cancer Supportive Care Medicine (2012-2023) 1.5.1 China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) 1.5.2 China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) 2 Industrial Chain Analysis 2.1 Industry Chain Structure of Cancer Supportive Care Medicine 2.2 Raw Material Analysis of Cancer Supportive Care Medicine 2.1.1 Raw Material A Market Analysis 2.1.2 Raw Material B Market Analysis 2.1.3 Raw Material C Market Analysis 2.3 Labor Cost Analysis of Cancer Supportive Care Medicine 2.4 Other Costs Analysis of Cancer Supportive Care Medicine 2.5 Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine 2.6 Manufacturing Process Analysis of Cancer Supportive Care Medicine 2.7 Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers in 2018 2.8 Downstream Buyers 3 China Cancer Supportive Care Medicine Players/Suppliers Profiles and Sales Data 3.1 Amgen 3.1.1 Company Basic Information, Manufacturing Base and Competitors 3.1.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.1.2.1 Product A 3.1.2.2 Product B 3.1.3 Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.1.4 Amgen Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.1.5 Amgen Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.2 Helsinn Healthcare 3.2.1 Company Basic Information, Manufacturing Base and Competitors 3.2.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.2.2.1 Product A 3.2.2.2 Product B 3.2.3 Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.2.4 Helsinn Healthcare Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.2.5 Helsinn Healthcare Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.3 Johnson &Johnson 3.3.1 Company Basic Information, Manufacturing Base and Competitors 3.3.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.3.2.1 Product A 3.3.2.2 Product B 3.3.3 Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.3.4 Johnson &Johnson Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.3.5 Johnson &Johnson Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.4 Merck 3.4.1 Company Basic Information, Manufacturing Base and Competitors 3.4.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.4.2.1 Product A 3.4.2.2 Product B 3.4.3 Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.4.4 Merck Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.4.5 Merck Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.5 F. Hoffmann-La Roche 3.5.1 Company Basic Information, Manufacturing Base and Competitors 3.5.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.5.2.1 Product A 3.5.2.2 Product B 3.5.3 F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.5.4 F. Hoffmann-La Roche Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.5.5 F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.6 GlaxoSmithKline 3.6.1 Company Basic Information, Manufacturing Base and Competitors 3.6.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.6.2.1 Product A 3.6.2.2 Product B 3.6.3 GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.6.4 GlaxoSmithKline Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.6.5 GlaxoSmithKline Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.7 Heron Therapeutics 3.7.1 Company Basic Information, Manufacturing Base and Competitors 3.7.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.7.2.1 Product A 3.7.2.2 Product B 3.7.3 Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.7.4 Heron Therapeutics Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.7.5 Heron Therapeutics Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.8 Kyowa Hakko Kirin 3.8.1 Company Basic Information, Manufacturing Base and Competitors 3.8.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.8.2.1 Product A 3.8.2.2 Product B 3.8.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.8.4 Kyowa Hakko Kirin Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.8.5 Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.9 Novartis 3.9.1 Company Basic Information, Manufacturing Base and Competitors 3.9.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.9.2.1 Product A 3.9.2.2 Product B 3.9.3 Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.9.4 Novartis Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.9.5 Novartis Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.10 TESARO 3.10.1 Company Basic Information, Manufacturing Base and Competitors 3.10.2 Cancer Supportive Care Medicine Product Category, Application and Specification 3.10.2.1 Product A 3.10.2.2 Product B 3.10.3 TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) 3.10.4 TESARO Different Types of Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) 3.10.5 TESARO Cancer Supportive Care Medicine Volume in Different Applications and Its Application Share 3.11 Teva Pharmaceutical Industries 4 China Cancer Supportive Care Medicine Competition by Players/Manufacturers, Region, Type and Application 4.1 China Cancer Supportive Care Medicine Market Competition by Players/Manufacturers 4.1.1 China Cancer Supportive Care Medicine Sales (K Units) and Market Share of Key Players/Suppliers (2012-2017) 4.1.2 China Cancer Supportive Care Medicine Revenue (Million USD) and Share by Players/Suppliers (2012-2017) 4.2 China Cancer Supportive Care Medicine Sales and Revenue by Type 4.2.1 China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type (2012-2017) 4.2.2 China Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Type (2012-2017) 4.3 China Cancer Supportive Care Medicine Sales and Revenue by Application 4.3.1 China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) 4.3.2 China Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Regions (2012-2017) 4.4 China Cancer Supportive Care Medicine Sales (K Units) by Application 5 South China Cancer Supportive Care Medicine (Sales, Revenue and Price) 5.1 South China Cancer Supportive Care Medicine Sales and Value (2012-2017) 5.1.1 South China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 5.1.2 South China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 5.1.3 South China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 5.2 South China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 5.3 South China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 6 East China Cancer Supportive Care Medicine (Sales, Revenue and Price) 6.1 East China Cancer Supportive Care Medicine Sales and Value (2012-2017) 6.1.1 East China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 6.1.2 East China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 6.1.3 East China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 6.2 East China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 6.3 East China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 7 Southwest China Cancer Supportive Care Medicine (Sales, Revenue and Price) 7.1 Southwest China Cancer Supportive Care Medicine Sales and Value (2012-2017) 7.1.1 Southwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 7.1.2 Southwest China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 7.1.3 Southwest China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 7.2 Southwest China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 7.3 Southwest China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 8 Northeast China Cancer Supportive Care Medicine (Sales, Revenue and Price) 8.1 Northeast China Cancer Supportive Care Medicine Sales and Value (2012-2017) 8.1.1 Northeast China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 8.1.2 Northeast China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 8.1.3 Northeast China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 8.2 Northeast China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 8.3 Northeast China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 9 North China Cancer Supportive Care Medicine (Sales, Revenue and Price) 9.1 North China Cancer Supportive Care Medicine Sales and Value (2012-2017) 9.1.1 North China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 9.1.2 North China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 9.1.3 North China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 9.2 North China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 9.3 North China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 10 Central China Cancer Supportive Care Medicine (Sales, Revenue and Price) 10.1 Central China Cancer Supportive Care Medicine Sales and Value (2012-2017) 10.1.1 Central China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 10.1.2 Central China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 10.1.3 Central China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 10.2 Central China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 10.3 Central China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 11 Northwest China Cancer Supportive Care Medicine (Sales, Revenue and Price) 11.1 Northwest China Cancer Supportive Care Medicine Sales and Value (2012-2017) 11.1.1 Northwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) 11.1.2 Northwest China Cancer Supportive Care Medicine Revenue and Growth Rate (2012-2017) 11.1.3 Northwest China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) 11.2 Northwest China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Type 11.3 Northwest China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application 12 Marketing Strategy Analysis, Distributors/Traders 12.1 Direct Marketing 12.1.1 Direct Marketing 12.1.2 Indirect Marketing 12.1.3 Marketing Channel Development Trend 12.2 Market Positioning 12.2.1 Pricing Strategy 12.2.2 Brand Strategy 12.2.3 Target Client 12.3 Distributors/Traders List 13 China Cancer Supportive Care Medicine Market Forecast (2018-2023) 13.1 China Cancer Supportive Care Medicine Sales (K Units), Revenue and Price Forecast (2018-2023) 13.1.1 China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) 13.1.2 China Cancer Supportive Care Medicine Revenue and Growth Rate Forecast (2018-2023) 13.1.3 China Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) 13.2 China Cancer Supportive Care Medicine Sales (K Units), Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.1 China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast by Region (2018-2023) 13.2.2 China Cancer Supportive Care Medicine Revenue and Growth Rate Forecast by Region (2018-2023) 13.2.3 South China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.4 East China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.5 Southwest China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.6 Northeast China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.7 Southwest China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.8 Central China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.2.9 Northwest China Cancer Supportive Care Medicine Sales, Revenue and Growth Rate Forecast (2018-2023) 13.3 China Cancer Supportive Care Medicine Sales, Revenue and Price Forecast by Type (2018-2023) 13.3.1 China Cancer Supportive Care Medicine Sales Forecast by Type (2018-2023) 13.3.2 China Cancer Supportive Care Medicine Revenue Forecast by Type (2018-2023) 13.3.3 China Cancer Supportive Care Medicine Price Forecast by Type (2018-2023) 13.4 China Cancer Supportive Care Medicine Sales Forecast by Application (2018-2023) 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology/Research Approach 15.1.1 Research Programs/Design 15.1.2 Market Size Estimation 15.1.3 Market Breakdown and Data Triangulation 15.2 Data Source 15.2.1 Secondary Sources 15.2.2 Primary Sources 15.3 Disclaimer

List of Tables and Figures Figure China Market Size (Million USD) Comparison 2012-2023 Table China Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Table China Cancer Supportive Care Medicine Sales (K Units) and Revenue (Million USD) Market Split by Product Type Table China Cancer Supportive Care Medicine Sales (K Units) by Application (2016-2023) Figure Product Picture of Cancer Supportive Care Medicine Table China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Comparison by Types (2012-2023) Figure China Cancer Supportive Care Medicine Sales (K Units) Market Share by Types in 2017 Figure Antiemetic Drugs Picture Figure Erythropoietin-Stimulating Agents Picture Figure Granulocyte-Stimulating Agents Picture Table China Cancer Supportive Care Medicine Sales (K Units) Comparison by Applications (2012-2023) Figure China Sales Market Share of Cancer Supportive Care Medicine by Applications in 2017 Figure Chemotherapy-Induced Anemia Picture Figure CINV Picture Figure Bone Metastasis Picture Table China Market Cancer Supportive Care Medicine Revenue (Million USD) Comparison by Regions 2012-2023 Figure South China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure East China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Southwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Northeast China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure North China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Central China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure Northwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2023) Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (2012-2023) Figure New Project SWOT Analysis of Cancer Supportive Care Medicine Table Industry News List of Cancer Supportive Care Medicine Figure Industry Chain Structure of Cancer Supportive Care Medicine Table Raw Material Suppliers and Price Analysis Figure Global Raw Material A Price Trend (USD/MT) Figure Global Raw Material B Price Trend (USD/MT) Figure Global Raw Material C Price Trend (USD/MT) Table Manufacturing Cost Structure Analysis of Cancer Supportive Care Medicine in 2017 Figure Manufacturing Process Analysis of Cancer Supportive Care Medicine Table Raw Materials Sources of Cancer Supportive Care Medicine Major Manufacturers China Table Major Buyers of Cancer Supportive Care Medicine Table Amgen Basic Information List Table Amgen Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Amgen Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Amgen Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Amgen Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Amgen Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Helsinn Healthcare Basic Information List Table Helsinn Healthcare Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Helsinn Healthcare Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Helsinn Healthcare Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Johnson &Johnson Basic Information List Table Johnson &Johnson Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Johnson &Johnson Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Johnson &Johnson Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Merck Basic Information List Table Merck Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Merck Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Merck Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Merck Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Merck Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table F. Hoffmann-La Roche Basic Information List Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure F. Hoffmann-La Roche Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table F. Hoffmann-La Roche Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table GlaxoSmithKline Basic Information List Table GlaxoSmithKline Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure GlaxoSmithKline Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table GlaxoSmithKline Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Heron Therapeutics Basic Information List Table Heron Therapeutics Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Heron Therapeutics Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Heron Therapeutics Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Kyowa Hakko Kirin Basic Information List Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Kyowa Hakko Kirin Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Novartis Basic Information List Table Novartis Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Novartis Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Novartis Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Novartis Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Novartis Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table Company TESARO Basic Information List Table Company TESARO Cancer Supportive Care Medicine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales Growth Rate (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Sales China Market Share (%) (2012-2017) Figure Company TESARO Cancer Supportive Care Medicine Revenue China Market Share (%) (2012-2017) Table Antiemetic Drugs Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Erythropoietin-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Granulocyte-Stimulating Agents Sales (K Units), Revenue (Million USD) and Price (USD/Unit) (2012-2017) Table Company TESARO Cancer Supportive Care Medicine Volume in Chemotherapy-Induced Anemia and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in CINV and Its Application Share Table Company TESARO Cancer Supportive Care Medicine Volume in Bone Metastasis and Its Application Share Table China Cancer Supportive Care Medicine Sales (K Units) by Players/Manufacturers (2012-2017) Table China Cancer Supportive Care Medicine Sales Share (%) by Players/Manufacturers (2012-2017) Figure 2016 China Cancer Supportive Care Medicine Sales Market Share (%) by Players/Manufacturers Figure 2017 China Cancer Supportive Care Medicine Sales Share by Players/Manufacturers Table China Cancer Supportive Care Medicine Revenue (Million USD) by Players/Manufacturers (2012-2017) Table China Cancer Supportive Care Medicine Revenue Market Share (%) Players/Manufacturers (2012-2017) Figure 2016 China Cancer Supportive Care Medicine Revenue Market Share (%) Players Figure 2017 China Cancer Supportive Care Medicine Revenue Market Share (%) Players Table China Cancer Supportive Care Medicine Sales (K Units) and Market Share (%) by Type (2012-2017) Table China Cancer Supportive Care Medicine Sales Share by Type (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure China Cancer Supportive Care Medicine Sales Growth Rate (%) by Type (2012-2017) Table China Cancer Supportive Care Medicine Revenue (Million USD) and Market Share (%) Type (2012-2017) Table China Cancer Supportive Care Medicine Revenue Market Share (%) Type (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Type (2012-2017) Figure China Cancer Supportive Care Medicine Revenue Growth Rate by Type (2012-2017) Table China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Regions (2012-2017) Table China Cancer Supportive Care Medicine Sales Share by Regions (2012-2017) Figure Sales Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure China Cancer Supportive Care Medicine Sales Market Share by Regions in 2017 Table China Cancer Supportive Care Medicine Revenue (Million USD) and Market Share by Regions (2012-2017) Table China Cancer Supportive Care Medicine Revenue Share (%) by Regions (2012-2017) Figure Revenue Market Share of Cancer Supportive Care Medicine by Regions (2012-2017) Figure China Cancer Supportive Care Medicine Revenue Market Share by Regions in 2017 Table China Cancer Supportive Care Medicine Sales (K Units) and Market Share by Application (2012-2017) Table China Cancer Supportive Care Medicine Sales Share (%) by Application (2012-2017) Figure China Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure China Cancer Supportive Care Medicine Sales Market Share by Application (2012-2017) Figure South China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) (2012-2017) Figure South China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure South China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table South China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table South China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure South China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table South China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table South China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure South China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure East China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure East China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure East China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table East China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table East China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure East China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table East China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table East China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure East China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Southwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Southwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Southwest China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Southwest China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Southwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Southwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Southwest China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Southwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Southwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Northeast China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Northeast China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northeast China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Northeast China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Northeast China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Northeast China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Northeast China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Northeast China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Northeast China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Central China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Central China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Central China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Central China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Central China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Central China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Central China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Central China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Central China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure North China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure North China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure North China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table North China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table North China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure North China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table North China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table North China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure North China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Figure Northwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (2012-2017) Figure Northwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) (2012-2017) Figure Northwest China Cancer Supportive Care Medicine Sales Price (USD/Unit) Trend (2012-2017) Table Northwest China Cancer Supportive Care Medicine Sales (K Units) by Type (2012-2017) Table Northwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type (2012-2017) Figure Northwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Type in 2017 Table Northwest China Cancer Supportive Care Medicine Sales (K Units) by Applications (2012-2017) Table Northwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications (2012-2017) Figure Northwest China Cancer Supportive Care Medicine Sales (K Units) Market Share by Applications in 2017 Table Distributors/Traders List Figure China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate Forecast (2018-2023) Figure China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure China Cancer Supportive Care Medicine Price and Trend Forecast (2018-2023) Table China Cancer Supportive Care Medicine Sales (K Units) Forecast by Regions (2018-2023) Figure China Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions (2018-2023) Figure China Cancer Supportive Care Medicine Sales (K Units) Market Share Forecast by Regions in 2023 Table China Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Regions (2018-2023) Figure China Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions (2018-2023) Figure China Cancer Supportive Care Medicine Revenue Market Share Forecast by Regions in 2023 Figure South China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure South China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Southwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure East China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure East China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northeast China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure North China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure North China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Central China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Central China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Cancer Supportive Care Medicine Sales (K Units) and Growth Rate (%) Forecast (2018-2023) Figure Northwest China Cancer Supportive Care Medicine Revenue (Million USD) and Growth Rate (%) Forecast (2018-2023) Table China Cancer Supportive Care Medicine Sales (K Units) Forecast by Type (2018-2023) Figure China Cancer Supportive Care Medicine Sales Market Share Forecast by Type (2018-2023) Table China Cancer Supportive Care Medicine Revenue (Million USD) Forecast by Type (2018-2023) Figure China Cancer Supportive Care Medicine Revenue Market Share Forecast by Type (2018-2023) Table China Cancer Supportive Care Medicine Price (USD/Unit) Forecast by Type (2018-2023) Table China Cancer Supportive Care Medicine Sales (K Units) Forecast by Application (2018-2023) Figure China Cancer Supportive Care Medicine Sales Market Share Forecast by Application (2018-2023) Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Amgen Helsinn Healthcare Johnson &Johnson Merck F. Hoffmann-La Roche GlaxoSmithKline Heron Therapeutics Kyowa Hakko Kirin Novartis TESARO Teva Pharmaceutical Industries